<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     caa a22        4500</leader>
  <controlfield tag="001">475762851</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20180406123556.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">170329e20001201xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1007/s005800070013</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)springer-10.1007/s005800070013</subfield>
  </datafield>
  <datafield tag="245" ind1="0" ind2="0">
   <subfield code="a">Prediction of Two- and Three-Amino-Acid Sequences of Acute Myeloid Leukaemia 1 Protein from its Amino Acid Composition</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
   <subfield code="c">[Guang Wu, Shao-Min Yan]</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">Abstract:: The repeated amino acid sequences in human acute myeloid leukaemia 1 protein (AML-1) are indispensable for its function and such repetitions cannot be simply attributed to chance. In order to fully explore the functional units in human AML-1, it may be necessary to analyse all the amino acid pairs, triplets, etc. along human AML-1 from one terminal to the next, to count their frequencies and calculate their probabilities. The amino-acid sequence of human AML-1 was counted according to two-, three- and four-amino acid sequences. The counted frequency and probability were compared with the predicted frequency and probability. The amino acid sequences, which appear in human AML-1 and can be predicted from its amino acid composition according to a purely random mechanism, are not deliberately evolved or conserved. By contrast, the amino acid sequences, which appear in human AML-1 but cannot be predicted from its amino acid composition according to a purely random mechanism, are deliberately evolved and conserved. Accordingly 77 (17.035%) and 41 (9.071%) of 452 two-amino acid sequences can be predicted by the frequency and probability according to a purely random mechanism. Some kinds of amino acid sequences, which are absent from human AML-1 but can be predicted from its amino acid composition according to a purely random mechanism, should not be excluded as possibilities in human AML-1. By contrast, some kinds of amino acid sequences, which are absent from human AML-1 and cannot be predicted from its amino acid composition according to a purely random mechanism, can be appropriately excluded from human AML-1. Accordingly 115 (63.187%) and 52 (28.571%) of 182 kinds of absent two-amino-acid sequences can be predicted by the frequency and probability according to a purely random mechanism and 7567 (99.881%) of 7576 kinds of absent three-amino-acid sequences can be predicted by the frequency according to a purely random mechanism.</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
   <subfield code="a">Springer-Verlag London Limited, 2000</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Key words: Amino acids sequence</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Human acute myeloid leukaemia 1 protein</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Prediction</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Wu</subfield>
   <subfield code="D">Guang</subfield>
   <subfield code="u">Laboratoire de Toxicocinétique et Pharmacocinétique, Faculté de Pharmacie, Université de la Méditerranée Aix-Marseille II, Marseille, France, FR</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Yan</subfield>
   <subfield code="D">Shao-Min</subfield>
   <subfield code="u">Cattedra di Anatomia Patologica, Dipartimento di Ricerche Mediche e Morfologiche, Facoltà di Medicina e Chirurgia, Università degli Studi di Udine, Udine, Italy, IT</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1007/s005800070013</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">research-article</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1007/s005800070013</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Wu</subfield>
   <subfield code="D">Guang</subfield>
   <subfield code="u">Laboratoire de Toxicocinétique et Pharmacocinétique, Faculté de Pharmacie, Université de la Méditerranée Aix-Marseille II, Marseille, France, FR</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Yan</subfield>
   <subfield code="D">Shao-Min</subfield>
   <subfield code="u">Cattedra di Anatomia Patologica, Dipartimento di Ricerche Mediche e Morfologiche, Facoltà di Medicina e Chirurgia, Università degli Studi di Udine, Udine, Italy, IT</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="a">Metadata rights reserved</subfield>
   <subfield code="b">Springer special CC-BY-NC licence</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-springer</subfield>
  </datafield>
 </record>
</collection>
